Epigenetic Regulation of MicroRNA Expression in Cancer

Methods in Molecular Biology

Volumn 676, Issue , 2011, Pages 165-184

  Choudhry, Hani ^a,b   Catto, James W F ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Cancer; DNA methylation; Epigenetic; Gene expression; Microarray; MicroRNA

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; AZACITIDINE; MICRORNA;

ARTICLE; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; NEOPLASM; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS;

MLCS; MLOWN;

EID: 79952201744     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-863-8_12     Document Type: Chapter

References (11)

1. Catto, J. W., Miah, S., Owen, H. C., Bryant, H., Dudziec, E., Larre, S., Milo, M., Rehman, I., Rosario, D. J., DiMartino, E., Knowles, M. A., Meuth, M., Harris, A. L., and Hamdy, F. C. (2009) Distinct microRNA alterations characterize high and low grade bladder cancer, Cancer Research 69, 8472–8481.
2. Lamy, P., Andersen, C. L., Dyrskjot, L., Torring, N., Orntoft, T., and Wiuf, C. (2006) Are microRNAs located in genomic regions associated with cancer? British Journal of Cancer 95, 1415–1418.
3. Croce, C. M. (2009) Causes and consequences of microRNA dysregulation in cancer, Nature Reviews 10, 704–714.
4. Saito, Y., Liang, G., Egger, G., Friedman, J. M., Chuang, J. C., Coetzee, G. A., and Jones, P. A. (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells, Cancer Cell 9, 435–443.
5. Lujambio, A., Calin, G. A., Villanueva, A., Ropero, S., Sanchez-Cespedes, M., Blanco, D., Montuenga, L. M., Rossi, S., Nicoloso, M. S., Faller, W. J., Gallagher, W. M., Eccles, S. A., Croce, C. M., and Esteller, M. (2008) A microRNA DNA methylation signature for human cancer metastasis, Proceedings of the National Academy of Sciences of the United States of America 105, 13556–13561.
6. Lehmann, U., Hasemeier, B., Christgen, M., Muller, M., Romermann, D., Langer, F., and Kreipe, H. (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer, Journal of Pathology 214, 17–24.
7. Saito, Y., and Jones, P. A. (2006) Epigenetic activation of tumor suppressor microRNAs in human cancer cells, Cell Cycle 5, 2220–2222.
8. Southgate, J., Hutton, K. A., Thomas, D. F., and Trejdosiewicz, L. K. (1994) Normal human urothelial cells in vitro: proliferation and induction of stratification, Laboratory Investigation 71, 583–594.
9. Catto, J. W., Azzouzi, A. R., Rehman, I., Feeley, K. M., Cross, S. S., Amira, N., Fromont, G., Sibony, M., Cussenot, O., Meuth, M., and Hamdy, F. C. (2005) Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma, Journal of Clinical Oncology 23, 2903–2910.
10. Yates, D. R., Rehman, I., Abbod, M. F., Meuth, M., Cross, S. S., Linkens, D. A., Hamdy, F. C., and Catto, J. W. (2007) Promoter hypermethylation identifies progression risk in bladder cancer, Clinical Cancer Research 13, 2046–2053.
11. Dhawan, D., Hamdy, F. C., Rehman, I., Patterson, J., Cross, S. S., Feeley, K. M., Stephenson, Y., Meuth, M., and Catto, J. W. (2006) Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma, Journal of Pathology 209, 336–343.